Individualized Homoeopathic Medicines in Treatment of Premenstrual Syndrome: Double- blind, Randomized, Placebo-controlled, Pilot Trial

ational Institute of Homoeopathy Ministry of AYUSH Govt of India0 个研究点目标入组 60 人开始时间: 待定最近更新: 2023年6月26日

试验速览

暂无简介。

•1. Cases suffering from PMS for more than 3 months, diagnosed as per ICD-10 criteria
•2. Patients taking oral contraceptive pills (OCPs) will be advised to stop pills till it exhaust for the ongoing cycle, followed by reassessment of PMS symptoms in the next cycle enrolment
•3. Patients under hormonal replacement therapy (HRT) to be included after a washout period of 3 months
•4. Literate patients; ability to read Bengali and/or English
•5. Patients giving written consent to participate

•1. PMDD states
•2. Patients underwent a hysterectomy and/or bilateral oophorectomy
•3. Primary or secondary amenorrhoea
•4. Change in hormone status (introduction of oestrogen and/or progestogen, amenorrhoea, pregnancy etc.)
•5. Patients having a history of breast or reproductive organ cancer
•6. Unevaluated gynaecological abnormalities; e.g. unexplained vaginal bleeding, cervical dysplasia, pelvic inflammatory diseases (PID) within
•one month, patients with suspicious adenomyosis, gross developmental defect or congenital abnormalities of the uterus etc.
•7. Patients with psychiatric diseases
•8. Cases suffering from uncontrolled systemic illness, life-threatening
•infections, or any vital organ failure
•9. Patients insisting to use OCPs and HRT
•10. Cases already undergoing homoeopathic treatment for any chronic purpose
•11. Substance abuse and/or dependence
•12.Self-reported immune-compromised state

发起方

ational Institute of Homoeopathy Ministry of AYUSH Govt of India